In Brief: Substance Abuse Technologies
This article was originally published in The Gray Sheet
Substance Abuse Technologies: Expands "all-in-one" drug testing panel test to include a simultaneous saliva alcohol test, the firm states. Expected to reach the market "within 18 months," the five-minute test would be the first "non-invasive combination drug and alcohol test that is quantitative and qualitative," SAT maintains. The Fort Lauderdale, Florida company also announces the launch of its AlcoProof System for quantitative and qualitative on-site alcohol testing. The system incorporates the AlcoProof Screen disposable test and the AlcoProof Confirm breath collection tube, which is sent to a lab for gas chromatography confirmation testing...
You may also be interested in...
Novartis has long championed the idea of making Sandoz an autonomous unit within the Swiss originator while stopping short of carving out the business altogether. Rumors continue to swirl around a potential deal, which was discussed during the recent virtual Meet Novartis Management event.
Health technology assessment body says that while iRhythm Technologies’ Zio XT service improves cardiac arrhythmia detection, more data must be collected to address evidence gaps about its benefit.
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.